PharmaShots | Incisive News in 3 Shots

Subscribe Now

TULIP 2 Study

AstraZeneca Reports Results of Anifrolumab in P-III TULIP 2 Study for Patients with Systemic Lupus Erythematosus

AstraZeneca Reports Results of Anifrolumab in P-III TULIP 2 Study for Patients with Systemic Lupus Erythematosus

August 29, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us